📊 This is a company profile preview from Tablestat.com Request a Free Trial Now

Company profile: Vallon Pharmaceuticals

1.1 - Company Overview

Vallon Pharmaceuticals Logo

Vallon Pharmaceuticals

Headquarter: United States
Founded: 20XX🔒
Employees: 100-500🔒

Company description

  • Provider of clinical-stage biopharmaceutical development focused on new medications for central nervous system disorders, including ADAIR, an investigational novel abuse-deterrent formulation of amphetamine immediate release.

Products and services

🔒

Key contacts

🔒
🔒

Financial details

🔒

1.2 - Competitors and similar companies to Vallon Pharmaceuticals

Reverse Medical Logo

Reverse Medical

HQ: United States Website
  • Description: Provider of commercial-stage medical devices focused on revascularizing patients experiencing acute ischemic stroke.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Reverse Medical company profile →
Prestwick Pharmaceuticals Logo

Prestwick Pharmaceuticals

HQ: United States Website
  • Description: Provider of therapeutic pharmaceutical drugs for chronic central nervous system diseases, offering products for restless legs syndrome, schizophrenia, autism, Alzheimer’s, and sleep apnea. Founded in 2002 and based in Washington, District of Columbia.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Prestwick Pharmaceuticals company profile →
Praxis Precision Medicines Logo

Praxis Precision Medicines

HQ: United States Website
  • Description: Provider of genetically informed therapies for CNS disorders characterized by neuronal excitation-inhibition imbalance, translating insights from epilepsies into treatments across rare to common conditions. Offers a clinical pipeline targeting movement disorders and epilepsies, conducts the Essential3, EMBOLD, and EMBRAVE studies, and considers expanded access to investigational drugs under specific conditions.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Praxis Precision Medicines company profile →
Noctrix Health Logo

Noctrix Health

HQ: United States Website
  • Description: Provider of early-stage medical device development, focusing on creating a revolutionary therapy for a chronic illness.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Noctrix Health company profile →
Premier Biotech Logo

Premier Biotech

HQ: United States Website
  • Description: Provider of drug testing diagnostic devices and laboratory services, including drugs of abuse testing delivering accurate results in under 10 minutes with observed collection to prevent adulteration. Offers the OT-Scan app for capturing and reporting drug screen results with automated test interpretation, secure data transmission, and in-app confirmation testing ordering.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Premier Biotech company profile →
🔒

2.M&A buyers

2.1 Potential strategic acquirers in the sector

🔒
🔒
🔒
🔒 View all strategic buyers with complete profiles
Start Free Trial →

2.2 - Strategic buyer groups for Vallon Pharmaceuticals

🔒

Buyer group 1: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔒

Buyer group 2: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔒

Buyer group 3: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →

3. Investors and private equity firms

3.1 - Buyout funds investing in similar companies to Vallon Pharmaceuticals

2.2 - Growth funds investing in similar companies to Vallon Pharmaceuticals

🔒 View all growth equity funds with complete profiles
Start Free Trial →

4 - Top valuation comps for Vallon Pharmaceuticals

4.2 - Public trading comparable groups for Vallon Pharmaceuticals

🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →

4.3 - M&A Transactions similar to Vallon Pharmaceuticals

Selected M&A transactions

Date Target Description Buyer(s) Relevance EV EV/Revenue EV/EBITDA
🔒 View all M&A transactions with complete deal terms
Request Free Trial Now →

Frequently Asked Questions

About Vallon Pharmaceuticals

What does Vallon Pharmaceuticals do?

Vallon Pharmaceuticals is a provider of clinical-stage biopharmaceutical development focused on new medications for central nervous system disorders, including ADAIR, an investigational novel abuse-deterrent formulation of amphetamine immediate release.

Who are Vallon Pharmaceuticals's competitors?

Vallon Pharmaceuticals's competitors and similar companies include Reverse Medical, Prestwick Pharmaceuticals, Praxis Precision Medicines, Noctrix Health, and Premier Biotech.

Where is Vallon Pharmaceuticals headquartered?

Vallon Pharmaceuticals is headquartered in United States.

How many employees does Vallon Pharmaceuticals have?

Vallon Pharmaceuticals has 1,000 employees 🔒.

When was Vallon Pharmaceuticals founded?

Vallon Pharmaceuticals was founded in 2010 🔒.

What sector and industry vertical is Vallon Pharmaceuticals in?

Vallon Pharmaceuticals is in the Enterprise Software 🔒 sector and industry

M&A Buyers & Acquirers for Vallon Pharmaceuticals

Who are the top strategic acquirers in Vallon Pharmaceuticals's sector and industry

Top strategic M&A buyers and acquirers in Vallon Pharmaceuticals's sector include ████████, ██████████, ██████, ████████, and ██████████ 🔒.

Which M&A buyer groups are most relevant for Vallon Pharmaceuticals?

Top strategic M&A buyers groups and sectors for Vallon Pharmaceuticals include █████████████████ , ████████████████, █████████████, ████████████, and ████████████████ 🔒.

Financial Investors investing in Vallon Pharmaceuticals's sector and industry vertical

Which are the top PE firms investing in Vallon Pharmaceuticals's sector and industry vertical?

Top PE firms investing in Vallon Pharmaceuticals's sector and industry vertical include ████████, ██████████, ████████, and ██████████ 🔒.

Who are the top buyout funds acquiring in Vallon Pharmaceuticals's sector and industry vertical?

Active PE funds and buyout funds acquiring companies in Vallon Pharmaceuticals's sector and industry vertical include █████████, ██████████, ████████████, and ████████████ 🔒.

Who are the top growth equity funds investing in companies in Vallon Pharmaceuticals's sector and industry vertical?

Growth funds and venture capital funds investing in companies similar to Vallon Pharmaceuticals include █████████, ██████████, ████████████, and ████████████ 🔒.

Valuation benchmarks of companies in Vallon Pharmaceuticals's sector and industry

Which are the key public companies that are relevant trading comps benchmarks for Vallon Pharmaceuticals?

The key public trading comparables and valuation benchmarks for Vallon Pharmaceuticals include █████████, ██████████, ████████████, and ████████████ 🔒.

Which are the key trading comparable groups for Vallon Pharmaceuticals for public valuation benchmarks?

Our platform tracks detailed public trading comparable groups and valuation benchmarks for Vallon Pharmaceuticals with complete valuation multiples, growth metrics, and profitability data. Access the full database to benchmark your company against relevant public comparables.

What are recent M&A transactions in Vallon Pharmaceuticals's sector and industry vertical?

Our platform tracks relevant M&A transactions comparables and valuation benchmarks for Vallon Pharmaceuticals with complete deal terms, valuation multiples, and strategic rationale. Access the full database to benchmark pricing and identify active acquirers.

What are recent capital raises and funding rounds in Vallon Pharmaceuticals's' sector and industry vertical?

Access recent funding rounds and capital raises in Vallon Pharmaceuticals's sector and industry vertical including growth equity, venture capital, and buyout investments. Our database includes round size, lead investors and valuations.

Ready to Find the Right Buyers?

Access complete buyer lists, valuation data, and M&A intelligence for Vallon Pharmaceuticals